302
Publications
42.4K
Citations
85
H-Index
1984
Active since
Jeffrey I. Weitz is an author at McMaster University specializing in medicine, thrombosis, and hematology.
Top concepts
MedicineThrombosisHematologyCardiovascular DiseasePharmacotherapyPharmacologyVascular BiologyAnesthesiologyPublic HealthAtherosclerosis
Publications per year
1984–2025
302
302
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano, Christian T. Ruff, Eugene Braunwald et al. · New England Journal of Medicine · 2013 · 5K citations · Full text
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Giancarlo Agnelli, Harry R. Büller, Alexander T. Cohen et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob, Nick van Es, Peter Verhamme et al. · New England Journal of Medicine · 2017 · 1.6K citations
Idarucizumab for Dabigatran Reversal
Charles V. Pollack, Paul A. Reilly, John W. Eikelboom et al. · New England Journal of Medicine · 2015 · 1.4K citations
Apixaban for Extended Treatment of Venous Thromboembolism
Giancarlo Agnelli, Harry R. Büller, Alexander T. Cohen et al. · New England Journal of Medicine · 2012 · 1.3K citations · Full text
Rows per page
1–5 of 302